Protagonist Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing some of their medical products and clinical research.
“PTG-100, an oral peptide antagonist of integrin α4β7 that alters trafficking of gut homing T cells in preclinical animal models”
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which offers proprietary peptide technology platform, which discovers and develops new chemical entities to address significant unmet medical needs. [Source: MarketWatch]
Company Website: http://www.protagonist-inc.com/